KeyBank National Association’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.37M | Buy |
44,144
+3,976
| +10% | +$748K | 0.03% | 260 |
|
|
2026
Q1 | $7.92M | Buy |
40,168
+13,148
| +49% | +$2.54M | 0.03% | 258 |
|
|
2025
Q4 | $4.97M | Buy |
27,020
+1,227
| +5% | +$215K | 0.02% | 300 |
|
|
2025
Q3 | $3.96M | Sell |
25,793
-1,664
| -6% | -$252K | 0.01% | 325 |
|
|
2025
Q2 | $3.84M | Buy |
27,457
+402
| +1% | +$56.3K | 0.01% | 330 |
|
|
2025
Q1 | $3.98M | Buy |
27,055
+2,897
| +12% | +$419K | 0.02% | 312 |
|
|
2024
Q4 | $3.17M | Buy |
24,158
+554
| +2% | +$77.6K | 0.01% | 353 |
|
|
2024
Q3 | $3.68M | Buy |
23,604
+157
| +0.7% | +$25.3K | 0.01% | 328 |
|
|
2024
Q2 | $3.66M | Buy |
23,447
+8
| +0% | +$1.2K | 0.02% | 316 |
|
|
2024
Q1 | $3.18M | Sell |
23,439
-3,525
| -13% | -$467K | 0.01% | 332 |
|
|
2023
Q4 | $3.63M | Buy |
26,964
+744
| +3% | +$96.7K | 0.02% | 312 |
|
|
2023
Q3 | $3.55M | Buy |
26,220
+25
| +0.1% | +$3.42K | 0.02% | 300 |
|
|
2023
Q2 | $3.75M | Sell |
26,195
-6,839
| -21% | -$1.01M | 0.02% | 304 |
|
|
2023
Q1 | $4.59M | Sell |
33,034
-308
| -0.9% | -$41.4K | 0.02% | 273 |
|
|
2022
Q4 | $4.52M | Buy |
33,342
+1,337
| +4% | +$168K | 0.02% | 274 |
|
|
2022
Q3 | $3.51M | Buy |
32,005
+1,169
| +4% | +$148K | 0.02% | 291 |
|
|
2022
Q2 | $4.08M | Sell |
30,836
-671
| -2% | -$88K | 0.02% | 281 |
|
|
2022
Q1 | $4.18M | Sell |
31,507
-6,022
| -16% | -$722K | 0.02% | 288 |
|
|
2021
Q4 | $4.37M | Buy |
37,529
+138
| +0.4% | +$16.2K | 0.02% | 290 |
|
|
2021
Q3 | $4.49M | Buy |
37,391
+2,074
| +6% | +$241K | 0.02% | 281 |
|
|
2021
Q2 | $4.23M | Buy |
35,317
+166
| +0.5% | +$18.2K | 0.02% | 285 |
|
|
2021
Q1 | $3.5M | Buy |
35,151
+746
| +2% | +$75K | 0.02% | 301 |
|
|
2020
Q4 | $3.44M | Sell |
34,405
-139
| -0.4% | -$14.7K | 0.02% | 295 |
|
|
2020
Q3 | $3.79M | Sell |
34,544
-30
| -0.1% | -$3.34K | 0.02% | 277 |
|
|
2020
Q2 | $3.66M | Buy |
34,574
+10
| +0% | +$1.03K | 0.02% | 279 |
|
|
2020
Q1 | $3.09M | Buy |
34,564
+35
| +0.1% | +$3.29K | 0.02% | 285 |
|
|
2019
Q4 | $3.44M | Buy |
34,529
+1,275
| +4% | +$120K | 0.02% | 302 |
|
|
2019
Q3 | $2.96M | Buy |
33,254
+97
| +0.3% | +$8.41K | 0.02% | 307 |
|
|
2019
Q2 | $2.74M | Buy |
33,157
+1,124
| +4% | +$88.1K | 0.02% | 323 |
|
|
2019
Q1 | $2.59M | Buy |
32,033
+2,791
| +10% | +$220K | 0.02% | 320 |
|
|
2018
Q4 | $2.22M | Buy |
29,242
+3,050
| +12% | +$238K | 0.01% | 325 |
|
|
2018
Q3 | $2.07M | Sell |
26,192
-14,192
| -35% | -$1.07M | 0.01% | 352 |
|
|
2018
Q2 | $2.84M | Sell |
40,384
-91
| -0.2% | -$6.55K | 0.02% | 304 |
|
|
2018
Q1 | $2.83M | Sell |
40,475
-565
| -1% | -$39.1K | 0.02% | 301 |
|
|
2017
Q4 | $2.85M | Buy |
41,040
+258
| +0.6% | +$17.4K | 0.02% | 299 |
|
|
2017
Q3 | $2.76M | Sell |
40,782
-1,175
| -3% | -$74.2K | 0.02% | 305 |
|
|
2017
Q2 | $2.86M | Sell |
41,957
-1,060
| -2% | -$69.2K | 0.02% | 297 |
|
|
2017
Q1 | $2.68M | Buy |
43,017
+1,836
| +4% | +$107K | 0.02% | 314 |
|
|
2016
Q4 | $2.25M | Sell |
41,181
-2,358
| -5% | -$134K | 0.01% | 346 |
|
|
2016
Q3 | $2.86M | Buy |
43,539
+3,528
| +9% | +$231K | 0.02% | 305 |
|
|
2016
Q2 | $2.42M | Sell |
40,011
-625
| -2% | -$36.3K | 0.02% | 316 |
|
|
2016
Q1 | $2.29M | Sell |
40,636
-2,464
| -6% | -$148K | 0.02% | 321 |
|
|
2015
Q4 | $2.93M | Buy |
43,100
+894
| +2% | +$58.6K | 0.02% | 292 |
|
|
2015
Q3 | $2.69M | Sell |
42,206
-524
| -1% | -$34.5K | 0.02% | 311 |
|
|
2015
Q2 | $2.72M | Sell |
42,730
-993
| -2% | -$68K | 0.02% | 324 |
|
|
2015
Q1 | $2.99M | Sell |
43,723
-657
| -1% | -$45.6K | 0.02% | 324 |
|
|
2014
Q4 | $3.12M | Buy |
44,380
+2,867
| +7% | +$205K | 0.02% | 312 |
|
|
2014
Q3 | $2.97M | Sell |
41,513
-952
| -2% | -$69.7K | 0.02% | 324 |
|
|
2014
Q2 | $3.16M | Sell |
42,465
-16,060
| -27% | -$1.16M | 0.02% | 321 |
|
|
2014
Q1 | $3.8M | Buy |
58,525
+715
| +1% | +$46.2K | 0.03% | 290 |
|
|
2013
Q4 | $3.43M | Buy |
57,810
+2,043
| +4% | +$111K | 0.02% | 303 |
|
|
2013
Q3 | $2.9M | Buy |
55,767
+1,187
| +2% | +$59.6K | 0.02% | 321 |
|
|
2013
Q2 | $2.58M | Buy |
+54,580
| New | +$2.78M | 0.01% | 588 |
|
Other funds holding AZN
EP
IA
KeyBank National Association's AZN Position: Q2 2026 in Review
KeyBank National Association increased its AstraZeneca (AZN) stake by 9.9% in Q2 2026, buying an estimated $748K and bringing the position to 44,144 shares worth $8.37M. The position accounts for 0.03% of the portfolio, ranked #260.
KeyBank National Association first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- KeyBank National Association held 44,144 shares of AstraZeneca worth $8.37M as of Q2 2026.
- KeyBank National Association bought 3,976 AstraZeneca shares in Q2 2026, an estimated $748K.
- AstraZeneca made up 0.03% of KeyBank National Association's portfolio in Q2 2026, its #260 holding.
- KeyBank National Association first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.